$MNDY

George James Case sold $161K of MNDY

George James Case (CRO) sold 1,773 shares of monday.com Ltd. (MNDY) at $90.79 ($0.16M total) on 2026-06-02.

Original reporting
SEC EDGAR · George James Case
Published Jun 3, 2026, 8:02 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 3, 2026, 8:17 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$MNDY
Neutral
medium confidence
Mentioned
$MNDY
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$MNDYNeutralLow
01

Why it matters

Insider selling can slightly pressure sentiment, but without additional company-specific news it usually has low trading impact.

02

Market read

A single officer sale at ~$90.79/share; potential minor sentiment effect only.

03

What to watch

The sale is not tied to a disclosed 10b5-1 plan in the filing, but the article provides no context on whether other insiders sold/bought or whether the company had concurrent news.

Relevance 6/10Novelty 6/10Timing: Filed 2026-06-03; sale executed 2026-06-02

Background

The article is an SEC Form 4 insider transaction disclosure for monday.com (MNDY).

Company-level read

Ticker impact

$MNDYNeutralMedium confidence
Context

monday.com’s CRO, George James Case, filed an open-market sale of 1,773 shares at ~$90.79 on 2026-06-02.

Expected impact

Likely limited near-term impact; any effect is typically sentiment-driven and small.

Evidence & confidence

Form 4 insider sales are common and the filing states no 10b5-1 plan, but the article provides no accompanying operational/financial catalyst.

Market effects

No direct sector read-through from a single insider sale disclosure.

None indicated.

None indicated.

Counterpoint

Insider selling can reflect diversification or liquidity needs rather than bearish expectations, especially for routine officer transactions.

Key entities

  • monday.com Ltd.

    Subject of the Form 4 insider transaction disclosure.

  • George James Case

    CRO who sold 1,773 shares in an open-market transaction.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$MNDYMed

Monday faces senior management exits amid AI restructuring

Israeli software company monday.com (MNDY) expects several senior management departures amid a restructuring and shift to AI-powered work platforms. The company announced a 20% workforce reduction in July, with restructuring costs estimated at $45M-$55M. Q2 2026 revenue was $364.6M, up 22% YoY, with net profit at $3.46M. Shares closed at $90, down 4% on the day and 37% YTD.

$CRMMed

Notable analyst calls: Salesforce, Walmart and Lockheed Martin gain analyst support as tech downgrades mount

Bank of America upgraded Salesforce (CRM) to Buy, raising its price target to $285, citing AI adoption and strong free cash flow. Barclays downgraded Dell (DELL), HPE (HPE), NetApp (NTAP), HubSpot (HUBS), and monday.com (MNDY) due to AI growth concerns. Deutsche Bank upgraded Walmart (WMT) to Buy, targeting $136, citing inflation benefits. RBC downgraded GoDaddy (GDDY) to Sector Perform, citing AI's impact. MongoDB (MDB) ratings reaffirmed by Needham and BofA.

$MNDYMed

Barclays downgrades 2 software stocks ahead of Q3 earnings

Barclays downgraded HubSpot and Monday.com to Equal Weight, citing delayed AI-driven growth. Analyst Raimo Lenschow expects AI growth at DigitalOcean and Datadog, and emerging at Microsoft. DigitalOcean and CoreWeave raised prices due to AI demand, with potential for revenue beats. Payroll software companies Paycom and Paylocity may see earnings beats.

$MNDYMed

Why is Monday.com stock rallying today?

Monday.com (MNDY) stock rose 5% after a prior downgrade and decline. JPMorgan cut its rating to Neutral, citing growth concerns. The company announced an AI-focused conference, and softer inflation data boosted tech stocks. Shares traded at $79.81, below the 52-week high of $210.49 but above the low of $57.50.